JF
IMGN

Jump Financial’s Immunogen Inc IMGN Stock Holding History

Jump Financial’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-113,128
Closed -$1.8M – 2380
2023
Q3 		$1.8M Sell
113,128
-144,290
-56% -$2.4M 0.07% 413
2023
Q2 		$4.86M Buy
257,418
+235,651
+1,083% +$2.78M 0.18% 120
2023
Q1 		$83.6K Buy
21,767
+7,953
+58% +$33.9K ﹤0.01% 1461
2022
Q4 		$68.5K Sell
13,814
-205,326
-94% -$1.11M ﹤0.01% 1472
2022
Q3 		$1.05M Buy
219,140
+187,519
+593% +$989K 0.04% 602
2022
Q2 		$142K Sell
31,621
-9,525
-23% -$41.4K 0.01% 1384
2022
Q1 		$196K Sell
41,146
-33,354
-45% -$185K 0.01% 1317
2021
Q4 		$553K Buy
74,500
+64,452
+641% +$401K 0.03% 607
2021
Q3 		$57K Buy
+10,048
New +$58.1K ﹤0.01% 1025
2021
Q2 		– Sell
-41,890
Closed -$339K – 1464
2021
Q1 		$339K Buy
+41,890
New +$342K 0.03% 566

Other funds holding IMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Jump Financial's IMGN Position: Q4 2023 in Review

Jump Financial sold out of Immunogen Inc (IMGN) in Q4 2023, closing a stake of 113,128 shares — an estimated $1.8M sold.

Jump Financial first reported a position in IMGN in Q1 2021 and held it in 10 quarters. The position peaked at $4.86M in Q2 2023. 327 funds tracked by Wall St. Rank hold IMGN as of Q4 2023.

  • Jump Financial reported no remaining Immunogen Inc position as of Q4 2023 after selling out during the quarter.
  • Jump Financial sold 113,128 Immunogen Inc shares in Q4 2023, an estimated $1.8M.
  • Jump Financial first reported a position in Immunogen Inc in Q1 2021 and held it in 10 quarters.
  • Jump Financial's Immunogen Inc position peaked at $4.86M in Q2 2023.
  • 327 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2023.

Based on Jump Financial's 13F filing for Q4 2023, filed 7 Feb 2024.